Within the patient groups, there were no significant difference in the CCL21 levels between those who were anti-CCL21 antibody positive or negative (SSc: p=0.84, SS: p=0.88, MCTD: p=0.92). The gene discussed is CCL21; the disease is synovial sarcoma.